Kura Oncology Income Statement (2022-2026) | KURA

Income Statement Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 14.11M15.29M20.75M17.34M18.27M
Gross Profit (Quarter) 14.11M18.00M
Operating items
Research & Development (Quarter) 25.19M28.18M29.33M32.53M36.27M39.73M41.70M52.27M55.97M65.26M
Selling, General & Administrative (Quarter) 11.37M11.82M13.14M14.23M18.18M16.68M18.18M24.07M22.84M31.55M
Other Operating Expenses (Quarter) 0.26M
Operating Expenses (Quarter) 36.57M40.00M42.47M46.76M54.45M56.40M59.88M76.34M78.81M97.08M
Operating Income (Quarter) -64.70M-78.81M
EBIT (Quarter) -49.13M-50.43M-53.99M-16.80M-64.70M-65.73M-73.72M197.79M-78.81M
Non-operating items
Interest & Investment Income (Quarter) 2.86M3.22M4.28M4.37M5.33M5.97M5.89M5.66M7.88M5.83M
Non Operating Income (Quarter) 2.50M2.83M3.87M3.98M4.93M5.57M5.48M5.26M7.50M5.49M
Net income details
EBT (Quarter) -49.52M-50.84M-54.40M-17.20M-57.20M-66.12M-74.12M197.44M-73.33M
Tax Provisions (Quarter) 0.23M0.07M0.01M
Profit After Tax (Quarter) -34.07M-37.17M-38.60M-42.79M-49.52M-50.84M-54.40M-19.22M-57.43M-66.12M-74.12M-81.00M-73.33M
Income from Continuing Operations (Quarter) -49.52M-50.84M-54.40M-17.20M-57.43M-66.12M-74.12M197.37M-73.33M
Consolidated Net Income (Quarter) -49.52M-50.84M-54.40M-17.20M-57.43M-66.12M-74.12M197.37M-73.33M
Income towards Parent Company (Quarter) -49.52M-50.84M-54.40M-17.20M-57.43M-66.12M-74.12M197.37M-73.33M
Net Income towards Common Stockholders (Quarter) -49.52M-50.84M-54.40M-17.20M-57.43M-66.12M-74.12M197.37M-73.33M
Additional items
EPS (Basic) (Quarter) -0.50-0.53-0.50-0.55-0.59-0.59-0.63-0.22-0.66-0.75-88.17-0.83
EPS (Weighted Average and Diluted) (Quarter) -0.50-0.53-0.50-0.55-0.59-0.59-0.63-0.22-0.66-0.75-0.852.25-0.83
Shares Outstanding (Weighted Average) (Quarter) 66.99M68.40M69.10M71.84M73.23M83.91M86.64M85.83M86.16M87.42M87.59M0.84M88.61M
Shares Outstanding (Diluted Average) (Quarter) 66.99M68.40M69.80M77.24M73.23M83.91M86.64M86.95M86.16M87.42M87.59M87.64M87.68M88.61M
EBITDA (Quarter) -31.93M-36.50M-36.91M-40.52M-49.07M-50.48M-52.83M-19.57M-57.22M-66.39M-73.91M-80.89M-74.74M
Interest Expenses (Quarter) 0.36M0.39M0.40M0.39M0.40M0.41M0.41M0.40M0.38M0.39M0.39M0.35M0.34M
Shares Outstanding (Quarter) 68.31M68.44M74.14M74.25M74.35M76.18M76.42M77.75M78.23M80.78M86.80M87.02M87.86M88.76M
Tax Rate (Quarter) -0.400.04-0.01